CD19 and systemic sclerosis: Thus, enhanced CD19 signaling induces hyperreactivity of B cell responses at the site of inflammation and enhances phenotypes of autoimmune diseases, while CD19 deficiency causes immunodeficiency and underscoring SSc phenotype.